ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105509; 2) Community: the network communities that were significantly associated with the response to NSC 105509; 3) Molecule: the relationships between components within communities and NSC 105509; 4) MDR: the compounds that were significantly associated with the NSC 105509.

NSC Compound Enrichment Correlation
NSC 175630 Toyocamycin, 6-amino- 0.000864859564133842 -0.33609928
NSC 352299 2-methylellpticinium 0.000864859564133842 0.20988231
NSC 356777 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1-hydroxy-7-oxo- 1,3,5-cycloheptriene-2-yl)- 0.000864859564133842 -0.28125503
NSC 740613 Imidazole-5-one deri 0.000864859564133842 0.54686143
NSC 95382 Camptothecin Derivative 0.000864859564133842 0.07743387
NSC 630004 1,4-Hydroquinone-2-methoxy-5-dimethylaminomethyl-6-(10-heptadecenyl)-(Z)-, hydrochloride 0.00107480559257737 -0.10293594
NSC 287459 Cytarabine AY 0.00107480559257738 -0.10338797
NSC 614495 B723735K022 0.00119931827492064 -0.13084096
NSC 623128 14-FLUORO-4-DEMETHOXYDAUNORUBICIN 0.00119931827492064 -0.01231525
NSC 107124 Camptothecin Derivative 0.00126952303154154 0.11547465
Total:57  Current:2    [First] [Prev] [Next] [Last]